Patents
Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
05/2007
05/09/2007CN1960978A Amine compound and organic electroluminescent element employing the same
05/09/2007CN1314686C Synthesis method of 2-amino-6-methyl-5-oxo-4-normal propyl-5-triazole [1,5-alpha] pyrimidine
05/09/2007CN1314393C Method for treating hair-dropping using thyromimetic compound
05/08/2007US7214802 Anti-cytokine heterocyclic compounds
05/08/2007US7214715 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques
05/08/2007US7214698 Beta-agonists, processes for preparing them and their use as pharmaceutical compositions
05/08/2007US7214677 Benzamide, heteroarylamide and reverse amides
05/08/2007CA2275479C Prevention of loss and restoration of bone mass by certain prostaglandin agonists
05/03/2007WO2007050087A1 N[S(4-aryl-triazol-3-yl)α -mercaptoacetyl]-p-amino benozoic acids AS HIV REVERSE TRANSCRIPTASE INHIBITORS
05/03/2007US20070100149 Process for preparing letrozole
05/03/2007US20070100148 Process for preparing anastrozole
05/03/2007US20070100031 Ultraviolet light absorbers
05/03/2007US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
05/02/2007EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands
05/02/2007EP1778644A2 Method of coloring with capped diazotized compound and coupling component
05/02/2007EP1658285B1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
05/02/2007EP0871774B1 Detection of nucleic acids and nucleic acid units
05/02/2007CN1313467C 6-(2,6-difluorophenyl)-triazolopyrimidines as fungecides
05/02/2007CN1313450C Tachykinin receptor antagonists
05/01/2007USRE39607 Herbicidal sulphonylamino(thio) carbonyl compounds
05/01/2007US7211675 2-(2H-Benzotriazole-2-yl)-4-bromomethylphenol; polymer stabilizer, compatible with polyolefins, polycarbonate, polystyrene and diene-elastomers
05/01/2007US7211669 therapy for depression; anxiolytic agents; eating disorders; post-traumatic stress disorders; headaches; drug addition; antiinflammatory agents
05/01/2007CA2305458C Nonsteroidal (hetero) cyclically-substituted acylanilides with mixed gestagenic and androgenic activity
05/01/2007CA2244836C Benzoheterocyclic derivatives as antidiabetic and antiobesity agents
05/01/2007CA2227205C Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles
04/2007
04/26/2007WO2007047306A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors
04/26/2007WO2007047305A1 Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors
04/26/2007WO2007045393A1 Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
04/26/2007WO2007045366A1 Heterocyclic compounds with carboxyl isostere groups and their use for the treatment of cardiovascular diseases
04/26/2007WO2007011696A3 Compositions and methods for coupling a plurality of compounds to a scaffold
04/26/2007WO2006120133A3 Process for coloring keratin fibers comprising metal complexes
04/26/2007WO2005012304A3 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
04/26/2007US20070093529 Diacylhydrazine derivatives
04/26/2007US20070093483 Use of derivatives of 2, 4-dihydro-[1,2,4] triazole-3-thione as inhibitors of the enzyme myeloperoxidase (mpo)
04/26/2007DE102005050497A1 Difluorphenol-Derivate und ihre Verwendung Difluorophenol derivatives and their use
04/26/2007DE102005050377A1 Heterocyclische Verbindungen und ihre Verwendung Heterocyclic compounds and their use
04/26/2007DE102005049953A1 Carbamoylbenzotriazol-derivate als Inhibitoren von Lipasen und Phospholipasen Carbamoylbenzotriazol derivatives as inhibitors of lipases and phospholipases
04/26/2007CA2626449A1 Heterocyclic compounds and their use
04/26/2007CA2625722A1 Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
04/26/2007CA2624904A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors
04/25/2007EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives
04/25/2007EP0949865A4 The use of cd4-binding small molecules to inhibit immune responses
04/25/2007CN1951947A Organometallic complex, and light-emitting element and light-emitting device using the same
04/25/2007CN1312137C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
04/25/2007CN1312136C Triazole derivatives as tachykinin receptor antagonists
04/25/2007CN1312135C Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents
04/24/2007USRE39590 3-(4-chloro-6-fluoro-3-methoxy-2-nitrophenyl)-6-trifluoromethyl-2,4(1H, 3H)-pyrimidinedione; useful for general or pre-emergent or post-emergent control of undesired plant species and defoliants at very low concentrations
04/24/2007US7208629 5′-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2007US7208512 Benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
04/24/2007US7208509 Non-nucleoside reverse transcriptase inhibitors
04/24/2007US7208504 Bicyclic inhibitors of hormone sensitive lipase
04/24/2007CA2320118C Process for preparing alkoxytriazolinones
04/24/2007CA2075173C Compounds and methods for inhibition of hiv and related viruses
04/19/2007WO2007043401A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
04/19/2007WO2007043400A1 Nitrogenated aromatic heterocyclic compound and pharmaceutical composition comprising the same
04/19/2007WO2007017546A3 Method of obtaining tryptamine derivatives
04/19/2007US20070088058 3-(1(S)(4-chlorobenzyl)-2(S)-((2-hydroxy-2-methyl-1-phenylpropyl)amino)propyl)-benzonitrile; obesity; potentiation; antagonists
04/19/2007US20070088037 Cancer and fibrotic diseases
04/19/2007CA2623327A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
04/18/2007EP1773790A1 Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors
04/18/2007EP1773786A2 Five-membered heterocycles useful as serine protease inhibitors
04/18/2007CN1950366A Thioether derivatives, their manufacture and use as pharmaceutical agents
04/18/2007CN1310905C Antivirally active heterocyclic azahexane derivatives
04/17/2007US7205325 Oxazole derivatives
04/12/2007WO2007041451A2 Ruthenium-catalyzed cycloaddition of alkynes and organic azides
04/12/2007WO2007039919A1 Crystalline forms of anastrozole
04/12/2007WO2007039913A1 Process for the preparation of 2,2’-[5-(1,2,4-triazole-1-ylmethyl) -1,3-phenylene] di (2-methylpropionitrile).
04/12/2007WO2007039912A1 A one pot process for the preparation of 4-[1-cyanophenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile
04/12/2007WO2007039110A2 α, α′-DIHYDROXY KETONE DERIVATIVES AND USE THEREOF AS UV FILTER
04/12/2007US20070082897 Acylated indanyl amines and their use as pharmaceuticals
04/12/2007DE102005047647A1 a,a'-Dihydroxyketonderivate und deren Verwendung als UV-Filter a, a'-dihydroxyketone derivatives and their use as UV filters
04/11/2007EP1694669B1 Novel compounds which are modulators of the ppar-type receptors and their use in cosmetic or pharmaceutical compositions
04/11/2007EP1471058B1 Process for producing 1,2,3-triazole compound
04/11/2007EP1392641B1 Substituted cyclohexane-1,4-diamine derivatives
04/11/2007CN1946680A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors
04/10/2007US7202367 Process for arylating or vinylating or alkynating a nucleophilic compound
04/10/2007US7202254 N-(p-(substituted 1,2,3-triazol-1-yl)phenyl) derivatives of cycloazaalkanes; particularly useful for treating methicillin-resistant Staphylococcus aureas infections
04/10/2007US7202253 Cycloalkyl inhibitors of potassium channel function
04/10/2007CA2159418C Stabilization of pigmented fiber with a synergistic mixture of hindered amine and uv absorber
04/05/2007WO2007038659A1 Violet laser excitable dyes and their method of use
04/05/2007WO2007038452A1 Process for synthesizing 1,2,4-triazoles
04/05/2007WO2007036533A2 Selected cgrp antagonists, a method for the production thereof and use in the form of drugs
04/05/2007WO2007036532A2 Selected cgrp antagonists, methods for the production thereof and their use as medicaments
04/05/2007CA2623156A1 Selected cgrp antagonists, methods for the production thereof and their use as medicaments
04/04/2007EP1770087A1 Selected CGRP antagonists, process for their preparation as well as their use as medicaments
04/04/2007EP1770086A1 Selected CGRP antagonists, process for their preparation as well as their use as medicaments
04/04/2007EP1769071A2 Proteomic analysis
04/04/2007CN1942457A 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
04/04/2007CN1942450A Process for the preparation of substituted triazole compounds
04/04/2007CN1308310C Nitrogenous aromatic ring compounds
04/04/2007CN1308297C Phenyl sulfamate derivatives
03/2007
03/29/2007WO2007015809A3 Hiv reverse transcriptase inhibitors
03/29/2007WO2006078676A3 Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
03/28/2007EP1765796A1 Substituted heteroaryl- and phenylsulfamoyl compounds
03/28/2007EP1765792A1 Sulfamic acid ester compounds useful in the inhibition of steroid sulphatase activity and aromatase activity
03/28/2007EP1399494B1 Method for the dimerisation of isophorone diisocyanate
03/28/2007CN1938308A Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
03/28/2007CN1938286A Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
03/28/2007CN1937921A 5,6-cycloalkyl-7-aminotriazolopyrimidines, method for production and use thereof for the prevention of fungal pests and agents comprising the same
03/28/2007CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 178